{"schema_version":"secwatch.filing_event.v1","accession":"0001818331-23-000027","form_type":"8-K","ticker":"WGS","cik":"0001818331","company_name":"GeneDx Holdings Corp.","filed_at":"2023-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.820101+00:00","generated_at":"2026-06-17T02:06:17.392751+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"GeneDx amends Executive Chairman agreement: reduced time, base salary $337,500","bullets":["Jason Ryan's employment as Executive Chairman extended to Dec 31, 2023.","For 2023, Ryan will work 50% time with base salary of $337,500.","Target annual performance bonus for 2023 set at 100% of base salary.","Amendment effective April 10, 2023; prior vesting End Date unchanged as Dec 31, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001818331-23-000027","json":"https://secwatch.observer/filing/0001818331-23-000027.json","markdown":"https://secwatch.observer/filing/0001818331-23-000027.md","text":"https://secwatch.observer/filing/0001818331-23-000027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818331/000181833123000027/0001818331-23-000027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818331/000181833123000027/smfr-20230412.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T02:06:17.392751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}